Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07667179

NAVO:J School-Based Group Intervention for Adolescent Mental Health

The purpose of this study is to determine and verify whether a school-based group intervention using the digital mental health platform NAVO:J can effectively improve the mental health of adolescents-particularly reducing depression, anxiety, and stress while enhancing resilience.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

7 year–19 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ajou Medical University

Suwon, 16499, South Korea

About this study

NAVO:J is a digital mental health platform designed to promote adolescent mental health.

The intervention will be conducted as a single-group pre-post design with students (N = 250 subjects) who apply for the Level 2-2 (group intervention) program.

The intervention period will be 17 weeks (17 sessions, once a week for about 40 minutes), with a mid-point evaluation at week 8 and a post-intervention evaluation at week 17.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Students who apply for the group intervention program
  • Possession of an internet-enabled smartphone
  • Consent to study participation by both the participant and their legal guardian

Exclusion criteria

  • Inability to install or run "NAVO:J" on the participant's smartphone
  • Current participation in another interventional study
  • A medical condition severe enough to preclude the intervention or outcome assessment
  • Judged by the researcher to be unlikely to participate cooperatively through the end of the study

Treatment and study plan

NAVO:J (digital mental health platform)

Behavioral

Participants use NAVO:J, a digital mental health platform developed for adolescents, delivered as a structured group intervention over 17 weeks (17 sessions, once weekly, approximately 40 minutes each). The platform provides algorithm-based recommended videos, 12 tailored "mind solutions" based on emotional-behavioral characteristics, self-assessments (personality, depression, anxiety, stress, self-esteem, smartphone use), expert-supported community features, mind coaching, growth tracking across 10 adolescent mental health indicators, and a mood diary. Sessions are facilitated weekly by trained researchers following a standardized manual.

Primary outcomes

  1. Change in Depression (PHQ-9)

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    Depression is measured using the Korean version of the Patient Health Questionnaire-9 (PHQ-9), based on the DSM-IV criteria for major depressive disorder, assessing symptoms experienced over the past two weeks. The scale consists of 9 items rated on a 4-point Likert scale (score range: 0-27). Higher scores indicate more severe depressive symptoms. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

  2. Change in Resilience (CD-RISC-10)

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    Resilience is measured using the 10-item Connor-Davidson Resilience Scale (CD-RISC-10), a self-report measure of an individual's ability to recover and adapt under adversity or stress. Each item is rated on a 5-point Likert scale (score range: 0-40). Higher scores indicate greater resilience. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

Secondary outcomes

  1. Change in Maum-EASY Anxiety and Depression Problems

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    The Maum-EASY Test is a self-report screening tool developed to detect students' mental health problems early and prevent worsening. The anxiety and depression subscale measures the level of anxiety- and depression-related problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of such problems (score range: 0-24). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

  2. Change in Maum-EASY Suicide and Crisis Problems

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    The suicide and crisis subscale of the Maum-EASY Test measures the level of serious risk symptoms such as suicidality and severe psychological problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater need for priority attention and intervention (score range: 0-18). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

  3. Change in Maum-EASY Externalizing Problems

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    The externalizing subscale of the Maum-EASY Test measures the level of outwardly expressed behavioral problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of problems such as oppositional behavior, delinquency, and habitual lying (score range: 0-24). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

  4. Change in Maum-EASY Psychological Trauma Problems

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    The psychological trauma subscale of the Maum-EASY Test measures the presence of traumatic experiences and related problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of problems such as intrusive memories, avoidance of others, and distrust of others (score range: 0-21). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

  5. Change in Maum-EASY School Life Adjustment

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    The school life adjustment subscale of the Maum-EASY Test measures difficulties related to school adjustment and reduced coping skills, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of problems such as lack of confidence, maladaptive coping, and difficulty making friends (score range: 0-21). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

  6. Change in Subjective Mental Health (VAS)

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    Subjective mental health is measured using a self-report Visual Analog Scale (VAS) developed by the research team to multidimensionally assess adolescents' perceived mental health. It consists of 9 items, each rated on an 11-point scale from 0 (not at all) to 10 (very much). It is used as a supplementary measure of overall perceived mental health. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

  7. Change in Empathy Quotient (K-EQ)

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    Empathy is measured using the Korean version of the Empathy Quotient (K-EQ), which assesses multidimensional empathic ability across cognitive empathy, emotional empathy, and social skills. It consists of 17 items rated on a 4-point Likert scale (score range: 17-68). Higher scores indicate greater empathic ability. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

  8. Change in Grit (GRIT-S)

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    Grit is measured using the Short Grit Scale (GRIT-S), comprising two subfactors: consistency of effort and consistency of interest. It consists of 8 items rated on a 5-point Likert scale (score range: 6-30). Higher scores indicate greater grit. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

Other outcomes

  1. Change in Big Five Personality Traits (BFI-K-10)

    Time frame: Baseline, week 8 (mid-point), week 17 (post-intervention)

    Personality is measured using a 15-item short form of the Big Five Inventory, comprising five subfactors: neuroticism, extraversion, openness, agreeableness, and conscientiousness. Each item is rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree) (score range: 15-75). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.

  2. NAVO:J App Log Data (Adherence)

    Time frame: Throughout the intervention period (week 1 to week 17)

    Objective adherence is assessed using NAVO:J platform log data, including app access time and the scope of activities completed during the study period. This measure is used to verify participant compliance with the intervention.

  3. Self-Reported Adherence Questionnaire

    Time frame: Week 17 (post-intervention)

    Subjective adherence is assessed using a self-report questionnaire on the number and duration of app sessions during the study period, administered at the post-intervention assessment.

  4. Smartphone App Satisfaction Questionnaire

    Time frame: Week 17 (post-intervention)

    App satisfaction is assessed using a self-report questionnaire evaluating ease of use, information reliability and quality, perceived improvement in mental health, and overall satisfaction, administered at the post-intervention assessment.

Study contacts

Contact information is provided by the study sponsor or research team.

Anna You

CONTACT

[email protected]

+82-31-219-4696

Yong Hyuk Choi

CONTACT

[email protected]

+82-31-219-5182

Sponsors and collaborators

Lead sponsor

Ajou University School of Medicine

Other

Registry information

Official study title

Effects of a School-Based Group Intervention Using the Digital Mental Health Platform NAVO:J on Adolescent Mental Health

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jun 24, 2026
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.